Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease

Liver Transplantation

Volumn 11, Issue 4, 2005, Pages 420-426

  Cuadrado, Antonio ^a   Fábrega, Emilio ^a   Casafont, Fernando ^a   Pons Romero, Fernando ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AZATHIOPRINE; CYCLOSPORIN A; PREDNISONE; STEROID;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COMORBIDITY; CONTROLLED STUDY; FEMALE; FISHER EXACT TEST; FOLLOW UP; FREQUENCY ANALYSIS; GRAFT INFECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT COMPLIANCE; PRIORITY JOURNAL; RECIDIVISM; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME;

ADULT; ALCOHOL DRINKING; CAUSE OF DEATH; COMORBIDITY; FEMALE; HUMANS; LIVER DISEASES, ALCOHOLIC; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 17344374272     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20386     Document Type: Article

References (41)

1. Pereira SP, Williams R. Alcohol relapse and functional outcome after liver transplantation for alcoholic liver disease. Liver Transpl 2001;7:204-205.
2. Pageaux GP, Bismuth M, Perney P, Costes V, Jaber S, Possoz P, et al. Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter? J Hepatol 2003;38:629-634.
3. Tome S, Lucey MR. Timing of liver transplantation in alcoholic cirrhosis. J Hepatol 2003;39:302-307.
4. Lucey MR, Carr K, Beresford TP, Fisher LR, Shieck V, Brown KA, et al. Alcohol use after liver transplantation in alcoholics: a clinical cohort follow-up study. Hepatology 1997;25:1223-1227.
5. Pageaux GP, Perney P, Larrey D. Liver transplantation for alcoholic liver disease. Addict Biol 2001;6:301-308.
6. Bravata DM, Olkin I, Barnato AE, Keeffe EB, Owens DK. Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: a systematic review. Liver Transpl 2001;7:191-203.
7. Bird GL, O'Grady JG, Harvey FA, Calne RY, Williams R. Liver transplantation in patients with alcoholic liver cirrhosis: selection criteria and rates of survival and relapse. BMJ 1990;301:15-17.
8. Kumar S, Stauber RE, Gavaler JS, Basista MH, Dindzans VJ, Schade RR, et al. Orthotopic liver transplantation for alcoholic liver disease. Hepatology 1990;11:159-164.
9. Knechtle SJ, Fleming MF, Barry KL, Steen D, Pirsch JD, Hafez GR, et al. Liver transplantation for alcoholic liver disease. Surgery 1992;112:694-703.
10. Gish RG, Lee AH, Keeffe EB, Rome H, Concepcion W, Esquivel CO. Liver transplantation for patients with alcoholism and end-stage liver disease. Am J Gastroenterol 1993;88:1337-1342.
11. Berlakovich GA, Steininger R, Herbst F, Balan M, Mittlbock M, Muhlbacber F. Efficacy of liver transplantation for alcoholic cirrhosis with respect to recidivism and compliance. Transplantation 1994;58:560-565.
12. Osorio RW, Ascher NL, Avery M, Bacchetti P, Roberts JP, Lake JR. Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology 1994;20:105-110.
13. Raakow R, Langrehr JM, Lohmann R, Knoop M, Keck H, Kling N, et al. Is orthotopic liver transplantation for end-stage alcoholic cirrhosis justified? Transplant Proc 1995;27:1241-1242.
14. Foster PF, Fabrega F, Karademir S, Sankary HN, Mital D, Williams JW. Prediction of abstinence from ethanol in alcoholic recipients following liver transplantation. Hepatology 1997;25: 1469-1477.
15. Anand AC, Ferra-Neto BH, Nightingale P, Mirza DF, White AC, McMaster P. Liver transplantation for alcoholic liver disease: evaluation of a selection protocol. Hepatology 1997;25: 1478-1484.
16. Fábrega E, Crespo J, Casafont F, De las Heras G, De la Peña J, Pons-Romero F. Alcoholic recidivism after liver transplantation for alcoholic cirrhosis. J Clin Gastroenterol 1998;26:204-206.
17. Pageaux GP, Michel J, Costes V, Perney P, Possoz P, Perrigault P-F, et al. Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism. Gut 1999;45:421-426.
18. Conjeevaram HS, Hart J, Lissoos TW, Schiano TD, Dasgupta K, Befeler AS, et al. Rapidly progressive liver injury and fatal alcoholic hepatitis occurring after liver transplantation in alcoholic patients. Transplantation 1999;67:1562-1568.
19. Gerhardt TC, Goldstein RM, Urschel HC, Tripp LE, Levy MF, Husberg BS, et al. Alcohol use following liver transplantation for alcohol cirrhosis. Transplantation 1996;62:1060-1063.
20. Lucey MR. Liver transplantation in the alcoholic patient. In: Maddrey WC, Schiff ER, Sorrel MF, eds. Transplantation of the Liver. Philadelphia, PA: Lipincott Williams and Wilkins, 2001:319-326.
21. Mackie J, Groves K, Hoyle A, Garcia C, Garcia R, Gunson B, et al. Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism. Liver Transpl 2001;7:418-427.
22. Berlakovich GA, Windhager T, Freundorfer E, Lesch OM, Steininger R, Muhlbacber F. Carbohydrate deficient transferrin for detection of alcohol relapse after orthotopic liver transplantation for alcoholic cirrhosis. Transplantation 1999;67:1231-1235.
23. Di Martini A, Day N, Dew MA, Lane T, Fitzgerald MG, Magill J, Jaun A. Alcohol use following liver transplantation: a comparison of follow-up methods. Psychosomatics 2001;42:55-62.
24. Georgiou G, Webb K, Griggs K, Copello A, Neuberger J, Day E. First report of a psychosocial intervention for patients with alcohol-related liver disease undergoing liver transplantation. Liver Transpl 2003;9:772-775
25. Everson G, Bharadhwaj G, House R, Talamantes M, Bilir B, Shrestha R, et al. Long-term follow-up of patients with alcoholic liver disease who underwent hepatic transplantation. Liver Transpl Surg 1997;3:263-274.
26. Farges O, Saliba F, Farhamant H, Samuel D, Bismuth A, Reynes M, et al. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins. Hepatology 1996;23:240-248.
27. Saigal S, Norris S, Muiesan P, Rela M, Heaton N, O'Grady J. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl 2002;8:482-487.
28. Watson RR. Ethanol, immunomodulation and cancer. Prog Food Nutr Sci 1998;12:189-209.
29. Roselle G, Mendenhall CL, Grossman CJ. Effects of alcohol on immunity and cancer. In: Yirmiya R, Taylor AN, eds. Alcohol, immunity, and cancer. Boca Raton, FL: CRC,; 1993:3-21.
30. Duvoux C, Delacroix I, Richardet JP, Roudot-Thoraval F, Metreau JM, Fagniez PL, et al. Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis. Transplantation 1999; 67:418-421.
31. Jain A, DiMartini A, Kashyap R, Youk A, Rohal S, Fung J. Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus. Transplantation 2000;70:1335-1342.
32. Levy M, Backman L, Husberg B, Goldstein R, McMillan R, Gibbs J, et al. De novo malignancy following liver transplantation: a single-center study. Transplant Proc 1993;25:1397-1399.
33. Jonas S, Rayes N, Neumann U, Neuhaus R, Bechstein WO, Guckelberger O, et al. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer 1997;80:1141-1150.
34. Kelly DM, Emre S, Guy SR, Miller CM, Schwartz ME, Sheiner PA. Liver transplant recipients are not at increased risk for non-lymphoid solid organ tumors. Cancer 1998;83:1237-1243.
35. Sheiner PA, Magliocca JF, Bodian CA, Kim-Schluger L, Altaca G, Guarrera JV, et al. Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation 2000;69:781-789.
36. Jain AB, Yee LD, Nalesnik MA, Youk A, Marsh G, Reyes J, et al. Comparative incidence of de novo malignancies after liver transplantation under tacrolimus using Surveillance Epidemiologic End Result data. Transplantation 1998;66:1193-1200.
37. Fung JJ, Jain A, Kwak EJ, Kusne S, Dvorchik I, Eghtesad B. De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl 2001;7(Suppl 1):S109-S118.
38. Penn I. Posttransplantation de novo tumors in liver allograft recipier. Liver Transpl Surg 1996;2:52-59.
39. Duvoux C, Pageaux GP, Vanlemmens C, Roudot-Thoraval F, Vincens-Rolland AL, Hézode C, et al. Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients. Transplantation 2002;74:1103-1109.
40. Darenkov IA, Marcarelli MA, Basadona GP, Friedman AL, Losber KM, Howe JG, et al. Reduced incidence of Epstein-Barr virus associated posttransplant lymphoproliferative disorder using preemtive antiviral therapy. Transplantation 1997;64:848-852.
41. US Registry (UNOS). http://www.unos.org. Richmond, VA: United Network for Organ Sharing, 2001. (Version current August 1, 2001).